These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24218360)

  • 21. [New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine].
    Ma J; Wang YL; Hu HM; Fox BA; Si LS
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):452-6. PubMed ID: 16188138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effector function-deficient memory CD8+ T cells clonally expand in the liver and give rise to peripheral memory CD8+ T cells.
    Su YC; Lee CC; Kung JT
    J Immunol; 2010 Dec; 185(12):7498-506. PubMed ID: 21078905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
    Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
    Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells.
    Walker EB; Haley D; Miller W; Floyd K; Wisner KP; Sanjuan N; Maecker H; Romero P; Hu HM; Alvord WG; Smith JW; Fox BA; Urba WJ
    Clin Cancer Res; 2004 Jan; 10(2):668-80. PubMed ID: 14760090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
    Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients.
    Casati A; Varghaei-Nahvi A; Feldman SA; Assenmacher M; Rosenberg SA; Dudley ME; Scheffold A
    Cancer Immunol Immunother; 2013 Oct; 62(10):1563-73. PubMed ID: 23903715
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Hu X; Majchrzak K; Liu X; Wyatt MM; Spooner CJ; Moisan J; Zou W; Carter LL; Paulos CM
    Cancer Res; 2018 Jul; 78(14):3888-3898. PubMed ID: 29769201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Location rather than CD62L phenotype is critical in the early establishment of influenza-specific CD8+ T cell memory.
    Kedzierska K; Stambas J; Jenkins MR; Keating R; Turner SJ; Doherty PC
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9782-7. PubMed ID: 17522251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.
    Kujawski M; Zhang C; Herrmann A; Reckamp K; Scuto A; Jensen M; Deng J; Forman S; Figlin R; Yu H
    Cancer Res; 2010 Dec; 70(23):9599-610. PubMed ID: 21118964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma.
    Tähtinen S; Blattner C; Vähä-Koskela M; Saha D; Siurala M; Parviainen S; Utikal J; Kanerva A; Umansky V; Hemminki A
    J Immunother; 2016; 39(9):343-354. PubMed ID: 27741089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central memory CD8+ T cells become CD69+ tissue-residents during viral skin infection independent of CD62L-mediated lymph node surveillance.
    Osborn JF; Hobbs SJ; Mooster JL; Khan TN; Kilgore AM; Harbour JC; Nolz JC
    PLoS Pathog; 2019 Mar; 15(3):e1007633. PubMed ID: 30875408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD62L (L-selectin) down-regulation does not affect memory T cell distribution but failure to shed compromises anti-viral immunity.
    Richards H; Longhi MP; Wright K; Gallimore A; Ager A
    J Immunol; 2008 Jan; 180(1):198-206. PubMed ID: 18097020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The initial draining lymph node primes the bulk of the CD8 T cell response and influences memory T cell trafficking after a systemic viral infection.
    Olson MR; McDermott DS; Varga SM
    PLoS Pathog; 2012; 8(12):e1003054. PubMed ID: 23236277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-specific CD8+ T cells maintain a semi-naive state following lymphopenia-induced proliferation.
    Johnson LD; Jameson SC
    J Immunol; 2010 May; 184(10):5604-11. PubMed ID: 20393139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine model.
    Díaz-Montero CM; El Naggar S; Al Khami A; El Naggar R; Montero AJ; Cole DJ; Salem ML
    Cancer Immunol Immunother; 2008 Apr; 57(4):563-72. PubMed ID: 17726606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifaceted Role of BTLA in the Control of CD8
    Ritthipichai K; Haymaker CL; Martinez M; Aschenbrenner A; Yi X; Zhang M; Kale C; Vence LM; Roszik J; Hailemichael Y; Overwijk WW; Varadarajan N; Nurieva R; Radvanyi LG; Hwu P; Bernatchez C
    Clin Cancer Res; 2017 Oct; 23(20):6151-6164. PubMed ID: 28754817
    [No Abstract]   [Full Text] [Related]  

  • 38. Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C).
    Salem ML; Díaz-Montero CM; Al-Khami AA; El-Naggar SA; Naga O; Montero AJ; Khafagy A; Cole DJ
    J Immunol; 2009 Feb; 182(4):2030-40. PubMed ID: 19201856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-primed, in vitro-activated CD4+ effector T cells establish long-term memory without exogenous cytokine support or ongoing antigen exposure.
    Wang LX; Plautz GE
    J Immunol; 2010 May; 184(10):5612-8. PubMed ID: 20382887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cells imprint adoptively transferred CD8
    Smith AS; Knochelmann HM; Wyatt MM; Rangel Rivera GO; Rivera-Reyes AM; Dwyer CJ; Ware MB; Cole AC; Neskey DM; Rubinstein MP; Liu B; Thaxton JE; Bartee E; Paulos CM
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.